FD extract significantly reduced the incidence of OSCC in the high-dose group from 100% to 14.3%. Cellular adhesion-enhancing antibodies, such as β-catenin and E-cadherin antibodies were found to have been dramatically downregulated in tumours treated with the FD extract, according to immunohistochemistry examination. This evidence concerns the gene CDH1 and neoplasm.